Ligand validation:3HAD

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 3HAD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3HAD_NAD_A_350	81%	6%	0.11	0.961	2.45	2.52	12	17	5	0	100%	1
3HAD_NAD_B_750	63%	6%	0.15	0.946	2.47	2.54	13	17	1	0	100%	1
1F0Y_NAD_B_750	86%	12%	0.099	0.968	2.44	1.69	10	13	0	0	100%	1
1IL0_NAD_B_750	77%	17%	0.122	0.961	2.09	1.55	9	9	2	0	100%	1
1M76_NAD_B_750	74%	19%	0.118	0.948	2.05	1.43	8	9	0	0	100%	1
1M75_NAD_B_750	65%	15%	0.139	0.94	2.19	1.61	8	9	1	0	100%	1
2HDH_NAD_A_350	60%	6%	0.137	0.923	2.55	2.47	15	17	0	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.